Rockefeller Capital Management’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $583K | Sell |
15,987
-1,470
| -8% | -$53.6K | ﹤0.01% | 1517 |
|
2025
Q1 | $675K | Sell |
17,457
-857
| -5% | -$33.1K | ﹤0.01% | 1393 |
|
2024
Q4 | $695K | Sell |
18,314
-1,759
| -9% | -$66.7K | ﹤0.01% | 1372 |
|
2024
Q3 | $842K | Sell |
20,073
-691
| -3% | -$29K | ﹤0.01% | 1280 |
|
2024
Q2 | $848K | Buy |
20,764
+3,860
| +23% | +$158K | ﹤0.01% | 1267 |
|
2024
Q1 | $701K | Buy |
16,904
+1,099
| +7% | +$45.5K | ﹤0.01% | 1375 |
|
2023
Q4 | $640K | Sell |
15,805
-856
| -5% | -$34.6K | ﹤0.01% | 1285 |
|
2023
Q3 | $652K | Buy |
16,661
+1,027
| +7% | +$40.2K | ﹤0.01% | 1230 |
|
2023
Q2 | $635K | Buy |
15,634
+150
| +1% | +$6.1K | ﹤0.01% | 1252 |
|
2023
Q1 | $648K | Sell |
15,484
-1,757
| -10% | -$73.5K | ﹤0.01% | 1235 |
|
2022
Q4 | $751K | Sell |
17,241
-8,916
| -34% | -$388K | ﹤0.01% | 1115 |
|
2022
Q3 | $1.02M | Buy |
26,157
+22,353
| +588% | +$867K | 0.01% | 1006 |
|
2022
Q2 | $161K | Buy |
3,804
+152
| +4% | +$6.43K | ﹤0.01% | 1711 |
|
2022
Q1 | $166K | Sell |
3,652
-14
| -0.4% | -$636 | ﹤0.01% | 1764 |
|
2021
Q4 | $177K | Buy |
3,666
+200
| +6% | +$9.66K | ﹤0.01% | 1692 |
|
2021
Q3 | $165K | Sell |
3,466
-96
| -3% | -$4.57K | ﹤0.01% | 1641 |
|
2021
Q2 | $172K | Buy |
3,562
+302
| +9% | +$14.6K | ﹤0.01% | 1567 |
|
2021
Q1 | $150K | Sell |
3,260
-8
| -0.2% | -$368 | ﹤0.01% | 1432 |
|
2020
Q4 | $155K | Sell |
3,268
-18
| -0.5% | -$854 | ﹤0.01% | 1275 |
|
2020
Q3 | $140K | Buy |
3,286
+696
| +27% | +$29.7K | ﹤0.01% | 1156 |
|
2020
Q2 | $106K | Buy |
2,590
+535
| +26% | +$21.9K | ﹤0.01% | 1145 |
|
2020
Q1 | $74K | Buy |
+2,055
| New | +$74K | ﹤0.01% | 1114 |
|